BILL · 2007–08 SESSION
SB 6630: Phase I/II clinical trials
Extending the tax incentives provided for qualified research and development to persons performing both phase I and II clinical trials.
Summary
- Persons specializing in Phase I and II clinical trials are eligible for the high technology R&D credit and deferral programs. R&D credits for Phase I and II clinical trials are not allowed for amounts received from a person eligible for the R&D credits for the same amounts.
From the Senate Bill Report (SB 6630), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedJan 21, 2008
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Jim Kastama (D-25)
- Introduced
- January 21, 2008 in the Senate
- Last action
- January 21, 2008
- Budget
- Has a fiscal note
AN ACT Relating to extending the tax incentives provided for qualified research and development to persons performing both phase I and II clinical trials;
Sponsors
Prime sponsor: Jim Kastama (D-25)
4 co-sponsors (4 Democrats, 0 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- First reading, referred to Ways & Means.
SB 6630 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 6630 (2019–20) Public housing authorities
- SB 6630 (2017–18) Farm internship program
- SB 6630 (2015–16) Rec. mineral prospecting
- SB 6630 (2011–12) Children's safe products
- SB 6630 (2009–10) Updating WASL references
- SB 6630 (2005–06) Threatening individuals
- SB 6630 (2003–04) Motorcycle insurance
- SB 6630 (2001–02) Electricians